GlassScriptPhysician profile
Jaime Henriquez
NPI 1922058718
$13,423.78
in general payments reported to CMS, 2019-2025
51 companies · $2,473 in 2025
The $2,473 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,773 · 2020: $444 · 2021: $1,116 · 2022: $1,568 · 2023: $2,399 · 2024: $1,651 · 2025: $2,473.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,502 · Education: $20.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,502.13 |
| Education | $20.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,944.95 | 2019-2025 | Dragonfly Opstar, Optis, Amplatzer |
| Edwards Lifesciences Corporation | $1,486.23 | 2019-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv), Pascal |
| Novartis Pharmaceuticals Corporation | $1,275.67 | 2019-2025 | |
| Pfizer INC. | $1,114.83 | 2019-2025 | |
| Boston Scientific Corporation | $682.19 | 2019-2025 | Watchman Flx, Sentinel, Varithena Administration Pack |
| Amgen INC. | $670.06 | 2019-2025 | Repatha, Repatha |
| Shockwave Medical, INC | $457.03 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $383.40 | 2019-2025 | Lifevest |
| Inari Medical, INC. | $379.79 | 2021-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| E.R. Squibb & Sons, L.L.C. | $330.97 | 2019-2025 | Eliquis, Camzyos |
| Janssen Pharmaceuticals, INC | $330.51 | 2019-2024 | Xarelto |
| Cardiva Medical, INC. | $323.29 | 2023-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade Mvp Xl Vvcs 10-12f, Cardiva Vascade 5f Vcs |
| Abiomed | $259.83 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $236.89 | 2022-2025 | Jardiance |
| Cordis US Corp. | $226.43 | 2025 | Mynx Control Venous, Mynx Control |
Show all 51 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jaime Henriquez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.